Half Year 2022 Oxford BioMedica PLC Earnings Call Transcript
Good afternoon, ladies and gentlemen, and welcome to the Oxford Biomedica Interim Results 2022 Conference Call and Webcast. (Operator Instructions) As a reminder, today's conference call is being recorded.
Good afternoon, and good morning, and welcome to Oxford Biomedica Half Year Results. I'm Roch Doliveux, I'm the Chairman of the Board and Interim CEO. And I'm joined today by Stuart and Kyri to share the update on Oxford Biomedica and then also with Sophia, who will help with the Q&A later on and all the questions you will have after this call.
So if I start with the first slide, I'm really pleased and excited about the momentum with Oxford Biomedica. Can I have Slide 3, please? And that momentum is really -- if I had to pick one KPI for you to remember, and we'll come back to this is our increase in customers by 70% over a year ago, and that's probably one of the best predictor of future revenues. The more fundamentals is you know that we had set up a new strategy, much more
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |